share_log

3: Initial statement of beneficial ownership of securities-10% Owner Nirland Ltd

3: Initial statement of beneficial ownership of securities-10% Owner Nirland Ltd

3:首次持股声明-股东 Nirland Ltd
美股SEC公告 ·  08/13 16:35

Moomoo AI 已提取核心信息

Conduit Pharmaceuticals Inc. has reported a significant change in ownership to the SEC, as detailed in a Form 3 filing dated August 6, 2024. The filing indicates that Nirland Ltd has acquired 12,500,000 shares of common stock and holds warrants for an additional 2,000,000 shares. The shares were issued in connection with a Senior Secured Promissory Note related to a business combination. Nirland Ltd is part of a group of entities including Stockton Ltd, The Rowland Master Trust, and Dovet Ltd, which collectively may be deemed to share beneficial ownership of the securities. The filing was signed by directors David Rowland and Barclay Rowland on behalf of the respective entities on August 13, 2024.
Conduit Pharmaceuticals Inc. has reported a significant change in ownership to the SEC, as detailed in a Form 3 filing dated August 6, 2024. The filing indicates that Nirland Ltd has acquired 12,500,000 shares of common stock and holds warrants for an additional 2,000,000 shares. The shares were issued in connection with a Senior Secured Promissory Note related to a business combination. Nirland Ltd is part of a group of entities including Stockton Ltd, The Rowland Master Trust, and Dovet Ltd, which collectively may be deemed to share beneficial ownership of the securities. The filing was signed by directors David Rowland and Barclay Rowland on behalf of the respective entities on August 13, 2024.
Conduit Pharmaceuticals公司已向SEC报告了重大的所有权变更,详细内容请参阅2024年8月6日的3号表格备案。备案显示Nirland有限公司已收购了1250万股普通股,并持有额外200万股的认股权证。这些股份是在与业务组合相关的Senior Secured Promissory Note中发行的。Nirland有限公司是包括Stockton有限公司、The Rowland Master Trust和Dovet有限公司在内的一组实体的一部分,这些实体共同可能被视为对这些证券拥有益处所有权。备案由董事David Rowland和Barclay Rowland代表各自的实体于2024年8月13日签署。
Conduit Pharmaceuticals公司已向SEC报告了重大的所有权变更,详细内容请参阅2024年8月6日的3号表格备案。备案显示Nirland有限公司已收购了1250万股普通股,并持有额外200万股的认股权证。这些股份是在与业务组合相关的Senior Secured Promissory Note中发行的。Nirland有限公司是包括Stockton有限公司、The Rowland Master Trust和Dovet有限公司在内的一组实体的一部分,这些实体共同可能被视为对这些证券拥有益处所有权。备案由董事David Rowland和Barclay Rowland代表各自的实体于2024年8月13日签署。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息